Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years

Clinical trial NCT02082639 · WITHDRAWN

Trial details

NCT number: NCT02082639
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Papillomavirus

Start date: 2015-02-01
Primary completion: 2015-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.